Condition

Renal Cell Carcinoma (Kidney Cancer) clinical trials and research

• 16Clinical trials
• 1New in 30 days
• 11Countries

Newest Renal Cell Carcinoma (Kidney Cancer) clinical trials

All recruiting trials (16)

• Cadonilimab and Lenvatinib in advanced kidney cancer

  This study tests whether Cadonilimab plus Lenvatinib can help adults with unresectable, advanced renal cell carcinoma, especially clear cell type, after prior treatments.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Panjiayuan Nanli · NCT07909265

• QLESP Block to Ease Pain After Robot-Assisted Kidney Surgery

  Doctors are testing a ultrasound-guided nerve block called QLESP to see if it lowers pain and reduces strong pain medicines after robotic partial nephrectomy in adults.

  Recruiting Huazhong University of Science and Technology · Wuhan, Hubei · NCT07704970

• Registry of Minimally Invasive Cancer Treatments Using Spectral Angio-CT Guidance

  This registry collects data from adults undergoing image-guided, minimally invasive cancer treatments to see if spectral angio-CT guidance helps predict outcomes and improve planning.

  Recruiting Leiden University Medical Center · Lyon, Auvergne-Rhône-Alpes and 2 other locations · NCT07636148

• Bone density changes with anti-PD-1 immunotherapy

  This pilot will test if anti-PD-1 immunotherapy changes bone density in adults starting approved anti-PD-1 treatment for certain early-stage cancers.

  Recruiting Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07555210

• Galectin-3 levels and outcomes with PD-1/PD-L1 therapy in kidney, bladder, lung, and liver cancer

  This study tests whether blood galectin‑3 levels before treatment predict outcomes for people with kidney, bladder, lung, or liver cancer who are starting PD‑1/PD‑L1 immunotherapy.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv, Israel · NCT07485114

• Template lymph node surgery plus kidney removal vs kidney removal alone for high-risk kidney cancer

  In people with high-risk kidney cancer, this study tests whether removing a broader set of lymph nodes during kidney removal helps people live longer and have their cancer stay away longer compared with removing only a few affected nodes.

  Recruiting Tianjin Medical University Second Hospital · Tianjin, Tianjin Municipality · NCT07321197

• Patient-partnered look at fear of cancer returning after kidney cancer surgery

  This project will work with people who had kidney cancer surgery and their partners to see if patient-led questions, timing, and digital methods can better identify fear that the cancer will come back.

  Recruiting at 3 sites Gødstrup Hospital · Aalborg and 2 other locations · NCT07234656

• 177Lu-TLX250 for advanced relapsed or recurrent clear-cell kidney cancer

  This will test whether 177Lu-TLX250, a CAIX-targeting radioligand, helps adults with CAIX-positive advanced or relapsed clear-cell kidney cancer who have had 2–3 prior therapies.

  Recruiting Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited · Sydney, New South Wales and 4 other locations · NCT07197580

• Abdominal CT offered alongside lung screening for people who have smoked

  We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.

  Recruiting University of Cambridge · Hull · NCT07171190

• CT-based AI to predict outcomes after kidney cancer surgery

  This project will try CT-based AI models to predict post-surgery outcomes for adults treated for kidney cancer.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07118813

• A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus

  This project will test whether a new prediction model can guide treatment choices to improve survival for adults with renal cell carcinoma, including those with venous tumor thrombus.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07117227

• 111In-XYIMSR-01 SPECT/CT to find metastatic clear-cell kidney cancer

  This trial tries a radioactive tracer called 111In-XYIMSR-01 during a SPECT/CT scan to see if it can find metastatic clear-cell kidney cancer in adults.

  Recruiting Phase 1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland · NCT07062549

• Digital symptom monitoring for people starting cabozantinib plus nivolumab for advanced clear-cell kidney cancer

  This project tests whether weekly digital self-reports of symptoms can help guide treatment management for adults beginning cabozantinib plus nivolumab for advanced clear-cell kidney cancer during the first three months.

  Recruiting at 3 sites Phase 4 Centre Francois Baclesse · Annecy and 18 other locations · NCT07028125

• Combining systemic therapy with stereotactic body radiotherapy for kidney cancer with limited spread

  This study is testing if adding a special type of radiation therapy to standard treatment can help people with kidney cancer that has spread a little bit live longer and feel better.

  Recruiting at 8 sites Phase 3 Sun Yat-sen University · Fuzhou, Fujian and 8 other locations · NCT06726421

• Testing KO-2806 for advanced solid tumors

  This study is testing a new treatment called KO-2806 for adults with advanced solid tumors that have certain genetic changes to see if it can help them feel better.

  Recruiting at 38 sites Phase 1 Kura Oncology, Inc. · Phoenix, Arizona and 37 other locations · NCT06026410

• Analyzing solid tumors for HLA loss and collecting T cells for CAR T-cell therapy

  This study is testing how often solid tumors lose a key protein that helps the immune system recognize them, while also collecting T cells from patients with high-risk cancers to prepare for future CAR T-cell therapy.

  Recruiting at 13 sites A2 Biotherapeutics Inc. · Gilbert, Arizona and 15 other locations · NCT04981119

Related topics

Quick answers

How many Renal Cell Carcinoma (Kidney Cancer) clinical trials are recruiting right now?

16, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in China (6 trials), United States (4 trials), France (3 trials), United Kingdom (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 1: 2, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →